Congress won’t include PhRMA-backed Medicare change in opioids package

PhRMA’s been trying all year to get Congress to relieve the industry of some of its responsibility for certain Medicare drug costs. It just lost again.
House Speaker Paul Ryan (R-Wis.) Source: Astrid Riecken/Getty Images

WASHINGTON — The latest version of a bill to address the opioid crisis will not include an unrelated, drug industry-backed provision that would relieve drug companies of some of their responsibility for certain Medicare drug costs, multiple lobbyists with knowledge of the bill told STAT.

The bill also will not include any version of the CREATES Act, a long-stalled bill to incentivize the production of cheaper generic and biosimilar drugs.

The opioids legislation, which

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readPolitics
These Republicans Campaigned On A Bold Drug-pricing Pledge. Since They Won, They’ve Gone Silent
These Republicans campaigned in 2018 on a pledge to allow Medicare to negotiate for drug prices. Since they won, they’ve gone silent.
STAT2 min read
California Names Former Google Scientist As The State’s ‘Mental Health Czar’
Dr. Tom Insel, a prominent neuroscientist who once led the National Institute of Mental Health, is going to be the “mental health czar” for the state of California.
STAT4 min readSociety
Opinion: Prejudice And Patient Choice: An Insidious Confluence In Medicine
Minority physicians like me often hear patients say things like, "I don't want your kind taking care of me!" That kind of racism has no place in health care.